• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Yehuda Handelsman on How Insulin Therapy Advances Can Boost Patients' Quality of Life

News
Video

With new technologies that allow insulin to be delivered much more easily and at a targeted speed, diabetes treatment is less likely to interfere with patients’ lives, explained Yehuda Handelsman, MD, FACP, FACE, FNLA, medical director and principal investigator at the Metabolic Institute of America.

With new technologies that allow insulin to be delivered much more easily and at a targeted speed, diabetes treatment is less likely to interfere with patients’ lives, explained Yehuda Handelsman, MD, FACP, FACE, FNLA, medical director and principal investigator at the Metabolic Institute of America.

Related Videos
Jessica Horwitz, MPH, FNP-C.
Craig A. Portell, MD, UVA Health
Jonathan Strober, MD, UCSF Benioff Children's Hospital
Eboni Price-Haywood, MD and Toni Flowers, PhD
Natalie Bedford sitting for a video interview
Dr Raymond Osarogiagbon
Christine Funke, MD
Dr Raymond Osarogiagbon
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.